These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6840844)

  • 41. Leukocyte elastase-independent proteolysis of gelatin-bound fibronectin by inflammatory macrophages.
    Daudi I; Gudewicz PW; Saba TM; Cho E; Frewin MB
    Inflammation; 1991 Dec; 15(6):481-95. PubMed ID: 1757131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of septic peritonitis on circulating fibronectin, immunoglobulin, and complement: relationship to reticuloendothelial phagocytic function.
    McCafferty MH; Saba TM
    Adv Shock Res; 1983; 9():241-55. PubMed ID: 6349306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opsonic fibronectin after operation or trauma: effect of hemodilution and duration of operation.
    Richards WO; Scovill WA; Anstine P
    South Med J; 1984 Oct; 77(10):1243-7. PubMed ID: 6484646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of fibronectins in peritoneal macrophages during the phagocytosis of Brucella. An immunocytochemical study by electron microscopy.
    Gay B; Mauss H; Sanchez-Teff S
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(2):169-76. PubMed ID: 2878532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Connective tissue proteins and phagocytic cell function. Laminin enhances complement and Fc-mediated phagocytosis by cultured human macrophages.
    Bohnsack JF; Kleinman HK; Takahashi T; O'Shea JJ; Brown EJ
    J Exp Med; 1985 May; 161(5):912-23. PubMed ID: 3157764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic removal of 125I-DLT gelatin after burn injury: a model of soluble collagenous debris that interacts with plasma fibronectin.
    Blumenstock FA; La Celle P; Herrmannsdoerfer A; Giunta C; Minnear FL; Cho E; Saba TM
    J Leukoc Biol; 1993 Jul; 54(1):56-64. PubMed ID: 8336079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phagocytosis and membrane fluidity: application to the evaluation of opsonizing properties of fibronectin.
    Muller S; Masson V; Droesch S; Donner M; Stoltz JF
    Biorheology; 1989; 26(2):323-30. PubMed ID: 2605336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis.
    Verbrugh HA; Keane WF; Hoidal JR; Freiberg MR; Elliott GR; Peterson PK
    J Infect Dis; 1983 Jun; 147(6):1018-29. PubMed ID: 6854062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered tissue-specific opsonic activities and opsono-recognition of liposomes in tumour-bearing rats.
    Moghimi SM; Patel HM
    Biochim Biophys Acta; 1996 Nov; 1285(1):56-64. PubMed ID: 8948475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating immunoreactive and bioassayable opsonic plasma fibronectin during experimental tumour growth.
    Saba TM; Gregory TJ; Blumenstock FA
    Br J Cancer; 1980 Jun; 41(6):956-65. PubMed ID: 7426320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis.
    Nielsen H; Espersen F; Kharazmi A; Antonsen S; Ejlersen E; Joffe P; Pedersen FB
    Am J Kidney Dis; 1992 Oct; 20(4):372-5. PubMed ID: 1415206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correction of serum opsonic defects after burn and sepsis by opsonic fibronectin administration.
    Lanser ME; Saba TM
    Arch Surg; 1983 Mar; 118(3):338-42. PubMed ID: 6824434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibronectin during CAPD-related peritonitis: no indications for intraperitoneal production.
    Zemel D; Koomen GC; Struijk DG; Krediet RT
    Blood Purif; 1993; 11(6):378-83. PubMed ID: 8043259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kupffer cell complement receptor clearance function after surgical injury and phagocytosis of immune complexes: effect of changes in plasma fibronectin.
    Loegering DJ; Kaplan JE; Vincent PA; Saba TM
    J Lab Clin Med; 1988 May; 111(5):504-10. PubMed ID: 3361229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the opsonic and monocyte adherence functions of the specific fibronectin fragment that enhances phagocytosis of particulate activators.
    Czop JK; Kadish JL; Zepf DM; Austen KF
    J Immunol; 1985 Mar; 134(3):1844-50. PubMed ID: 3968434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased plasma fibronectin during starvation in man.
    Howard L; Dillon B; Saba TM; Hofmann S; Cho E
    JPEN J Parenter Enteral Nutr; 1984; 8(3):237-44. PubMed ID: 6429359
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.
    Cameron JS
    Pediatr Nephrol; 1995 Oct; 9(5):647-62. PubMed ID: 8580033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated ascitic fluid fibronectin concentration. A non-specific finding.
    Runyon BA
    J Hepatol; 1986; 3(2):219-22. PubMed ID: 3794302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma fibronectin therapy and lung protein clearance with bacteremia after surgery.
    Cohler LF; Saba TM; Lewis E; Vincent PA; Charash WE
    J Appl Physiol (1985); 1987 Aug; 63(2):623-33. PubMed ID: 3654422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular reactions in a SRBC-induced inflammatory exudate.
    Slonecker CE
    Anat Rec; 1973 Jun; 176(2):129-41. PubMed ID: 4711441
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.